Ftse Mib
33.766,29
-0,06%
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
1,03%
Bitcoin
98.746,60
1,01%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Vor Biopharma Inc (VOR) Vor Biopharma Inc (VOR) Notizie

VOR

Vor Biopharma (VOR)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:VOR
DataOraFonteTitoloSimboloCompagnia
09/12/202413:39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VORVor Biopharma Inc
09/12/202413:30GlobeNewswire Inc.Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial DesignNASDAQ:VORVor Biopharma Inc
14/11/202422:33Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:VORVor Biopharma Inc
12/11/202414:00GlobeNewswire Inc.Vor Bio to Participate in the Stifel 2024 Healthcare ConferenceNASDAQ:VORVor Biopharma Inc
08/11/202422:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
07/11/202422:05GlobeNewswire Inc.Vor Bio Reports Third Quarter 2024 Financial Results and Provides Company UpdateNASDAQ:VORVor Biopharma Inc
07/11/202422:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VORVor Biopharma Inc
02/10/202422:16Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
30/09/202413:00GlobeNewswire Inc.Vor Bio Appoints Seasoned Healthcare Institutional Investor, Han Choi, M.D., LL.M., as Chief Financial OfficerNASDAQ:VORVor Biopharma Inc
05/09/202422:01GlobeNewswire Inc.New Clinical Data Validates Vor Bio’s Approach of Using Shielded Transplants to Deliver Targeted TherapiesNASDAQ:VORVor Biopharma Inc
28/08/202414:00GlobeNewswire Inc.Vor Bio to Participate in Upcoming Investor ConferencesNASDAQ:VORVor Biopharma Inc
08/08/202422:13Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:VORVor Biopharma Inc
08/08/202422:05GlobeNewswire Inc.Vor Bio Reports Second Quarter 2024 Financial Results and Provides Company UpdateNASDAQ:VORVor Biopharma Inc
02/08/202422:01GlobeNewswire Inc.Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VORVor Biopharma Inc
19/07/202423:04Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VORVor Biopharma Inc
09/05/202422:05GlobeNewswire Inc.Vor Bio Reports First Quarter 2024 Financial Results and Provides Company UpdateNASDAQ:VORVor Biopharma Inc
02/05/202422:01GlobeNewswire Inc.Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of DirectorsNASDAQ:VORVor Biopharma Inc
20/03/202421:05GlobeNewswire Inc.Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company UpdateNASDAQ:VORVor Biopharma Inc
14/02/202422:08Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VORVor Biopharma Inc
07/02/202414:00GlobeNewswire Inc.Vor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:VORVor Biopharma Inc
17/01/202422:01GlobeNewswire Inc.Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate UpdateNASDAQ:VORVor Biopharma Inc
27/11/202314:00GlobeNewswire Inc.Vor Bio to Participate in the JMP Securities Hematology and Oncology SummitNASDAQ:VORVor Biopharma Inc
09/11/202322:01GlobeNewswire Inc.Vor Bio Presents Positive Data Update on Trem-cel at HSCT² ConferenceNASDAQ:VORVor Biopharma Inc
07/11/202322:05GlobeNewswire Inc.Vor Bio Reports Third Quarter 2023 Financial Results and Provides Company UpdateNASDAQ:VORVor Biopharma Inc
02/11/202314:01GlobeNewswire Inc.Multiple Clinical and Preclinical Presentations at ASH 2023 Highlight Vor Bio’s Novel eHSC and CAR-T PlatformNASDAQ:VORVor Biopharma Inc
30/08/202322:51Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VORVor Biopharma Inc
10/08/202322:05GlobeNewswire Inc.Vor Bio Reports Second Quarter 2023 Financial Results and Provides Company UpdateNASDAQ:VORVor Biopharma Inc
01/08/202314:00GlobeNewswire Inc.Vor Bio to Participate in the Wedbush PacGrow Healthcare ConferenceNASDAQ:VORVor Biopharma Inc
09/06/202313:42Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VORVor Biopharma Inc
09/06/202313:30GlobeNewswire Inc.Successful Primary Engraftment of Trem-cel in First Five AML Patients Demonstrates Promise of Vor Bio’s PlatformNASDAQ:VORVor Biopharma Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:VOR

La tua Cronologia

TSX
QAH
Mackenzie US Large Cap E...
TSX
LYCT
Lysander Canso Corporate...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network